TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients

Lung Cancer

Volumn 71, Issue 2, 2011, Pages 209-216

  Yoon, Sun Och ^a,b,d   Kim, Young Tae ^a   Jung, Kyeong Cheon ^a   Jeon, Yoon Kyung ^a,b   Kim, Baek Hui ^c   Kim, Chul Woo ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Circulating tumor cell; Cytokeratin 19; Metastasis; Non small cell lung cancer; Real time reverse transcription PCR; Thyroid transcription factor 1

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA; THYROID TRANSCRIPTION FACTOR 1;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LOCAL METASTASIS; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; KERATIN-19; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; NUCLEAR PROTEINS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650942408     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.04.017     Document Type: Article

References (35)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Brundage M.D., Davies D., Mackillop W.J. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002, 122:1037-1057.
3. Furak J., Trojan I., Szoke T., Agocs L., Csekeo A., Kas J., et al. Lung cancer and its operable brain metastasis: survival rate and staging problems. Ann Thorac Surg 2005, 79:241-247. [discussion 241-7].
4. Husemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
5. Pantel K., Brakenhoff R.H., Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008, 8:329-340.
6. Cristofanilli M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol 2006, 33:S9-14.
7. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
8. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
9. Maheswaran S., Sequist L.V., Nagrath S., Ulkus L., Brannigan B., Collura C.V., et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008, 359:366-377.
10. Mocellin S., Hoon D., Ambrosi A., Nitti D., Rossi C.R. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res 2006, 12:4605-4613.
11. Schuster R., Bechrakis N.E., Stroux A., Busse A., Schmittel A., Scheibenbogen C., et al. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Clin Cancer Res 2007, 13:1171-1178.
12. Stathopoulou A., Ntoulia M., Perraki M., Apostolaki S., Mavroudis D., Malamos N., et al. A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer. Int J Cancer 2006, 119:1654-1659.
13. Iinuma H., Okinaga K., Egami H., Mimori K., Hayashi N., Nishida K., et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol 2006, 28:297-306.
14. Chen T.F., Jiang G.L., Fu X.L., Wang L.J., Qian H., Wu K.L., et al. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor. Lung Cancer 2007, 56:105-114.
15. Jerome Marson V., Mazieres J., Groussard O., Garcia O., Berjaud J., Dahan M., et al. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology 2004, 45:125-134.
16. Sher Y.P., Shih J.Y., Yang P.C., Roffler S.R., Chu Y.W., Wu C.W., et al. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res 2005, 11:173-179.
17. Lazzaro D., Price M., de Felice M., Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991, 113:1093-1094.
18. Ordonez N.G. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 2000, 7:123-127.
19. Pelosi G., Fraggetta F., Pasini F., Maisonneuve P., Sonzogni A., Iannucci A., et al. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol 2001, 25:363-372.
20. Edge S.B., American Join Committee on Cancer, American Cancer Society AJCC cancer staging manual 2010, Springer-Verlag, New York. 7th ed.
21. Travis W.D., World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology Pathology and genetics of tumours of the lung, pleura, thymus and heart 2004, IARC Press, Lyon.
22. Liu Z., Jiang M., Zhao J., Ju H. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res 2007, 13:2992-2997.
23. Hoffmann A.C., Warnecke-Eberz U., Luebke T., Prenzel K., Metzger R., Heitmann M., et al. Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers. J Surg Oncol 2007, 95:51-54.
24. Demicheli R., Retsky M.W., Hrushesky W.J., Baum M. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat Clin Pract Oncol 2007, 4:699-710.
25. Wicha M.S. Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res 2006, 12:5606-5607.
26. Ntoulia M., Stathopoulou A., Ignatiadis M., Malamos N., Mavroudis D., Georgoulias V., et al. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR. Clin Biochem 2006, 39:879-887.
27. Xenidis N., Perraki M., Kafousi M., Apostolaki S., Bolonaki I., Stathopoulou A., et al. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol 2006, 24:3756-3762.
28. Ignatiadis M., Kallergi G., Ntoulia M., Perraki M., Apostolaki S., Kafousi M., et al. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res 2008, 14:2593-2600.
29. Balic M., Lin H., Young L., Hawes D., Giuliano A., McNamara G., et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006, 12:5615-5621.
30. Alix-Panabieres C., Vendrell J.P., Pelle O., Rebillard X., Riethdorf S., Muller V., et al. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 2007, 53:537-539.
31. Bishop A.E. Pulmonary epithelial stem cells. Cell Prolif 2004, 37:89-96.
32. Otto W.R. Lung epithelial stem cells. J Pathol 2002, 197:527-535.
33. Fujita J., Ohtsuki Y., Bandoh S., Ueda Y., Kubo A., Tojo Y., et al. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines. Lung Cancer 2003, 39:31-36.
34. Nakamura N., Miyagi E., Murata S., Kawaoi A., Katoh R. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Mod Pathol 2002, 15:1058-1067.
35. Kowalewska M., Chechlinska M., Markowicz S., Kober P., Nowak R. The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes. Eur J Cancer 2006, 42:2671-2674.